The two acyl-homoserine lactones (AHLs) N-(butyryl)-L-homoserine lactone and N-[3-oxododecanoyl]-L-homoserine lactone (3-oxo-C 12 -HSL) are required for quorum sensing in Pseudomonas aeruginosa. These AHLs derive their invariant lactone rings from S-adenosylmethionine and their variable acyl chains from the cellular acyl-acyl carrier protein (ACP) pool. This reaction is catalysed by specific AHL synthases, which exhibit acyl chain specificity. Culture supernatants of P. aeruginosa contain multiple 3-oxo-AHLs that differ in their acyl chain lengths but their physiological role, if any, remains unknown. An in vitro fatty acid-3-oxo-AHL synthesis system was established utilizing purified P. aeruginosa Fab proteins, ACP and the LasI 3-oxo-AHL synthase. In the presence of excess protein, substrates and cofactors, this system produced almost exclusively 3-oxo-C 12 -HSL. When the β-ketoacyl-ACP reductase (FabG) catalysed step was made rate-limiting by switching from the preferred NADPH cofactor to NADH, increased levels of short chain 3-oxo-AHLs were produced, presumably because shorter-chain ketoacyl-ACPs accumulated and thus became LasI substrates. Consistent with these in vitro observations, a fabG(Ts) mutant produced increased amounts of 3-oxo-AHLs in vivo. Thus, in vitro and in vivo evidence indicated that modulation of FabG activity of the fatty acid biosynthetic pathway may determine the acyl chain lengths of these 3-oxoAHLs and that the LasI 3-oxo-AHL synthase is sufficient for their synthesis.
INTRODUCTION
The expression of many extracellular Pseudomonas aeruginosa virulence factors (Passador et al., 1993 ; Van Delden & Iglewski, 1998) and other cellular processes, such as biofilm maturation in vitro (Davies et al., 1998) and biofilm formation in the lungs of cystic fibrosis There are several potential pathways to generate acetoacetyl-ACP and initiate fatty acid synthesis (Cronan & Rock, 1996) but not all are shown for the sake of clarity. In the reaction shown, which explains the in vitro system established in this study, malonyl-ACP is decarboxylated to acetyl-ACP by FabB, which then condenses these two molecules to acetoacetyl-ACP to initiate the cycle (Cronan & Rock, 1996) . The malonyl-ACP is derived from malonyl-CoA by malonyl-CoA : ACP acyltransferase (FabD). Subsequent cycles are initiated by condensation of malonyl-ACP with acyl-ACP, catalysed by FabB (β-ketoacyl ACP synthase I). The β-ketoacyl-ACP from the FabB reaction is reduced to a β-hydroxyacyl-ACP by FabG, a NADPH-dependent β-ketoacyl-ACP reductase. The subsequent dehydration step is catalysed by either FabA or FabZ, depending on the lengths of the acyl groups in the β-hydroxyacyl-ACP substrates. The final step involves reduction of the dehydratase product to an acyl-ACP via FabI, a NADH-dependent enoyl-ACP reductase. Subsequent cycles are initiated by a FabB-catalysed condensation of malonyl-ACP with acyl-ACP. For synthesis of 3-oxo-C 12 -HSL, LasI utilizes the 3-oxododecanoyl-ACP from the Fab pathway. Similarly, RhlI uses crotonyl-ACP for synthesis of C 4 -HSL. Enzymes involved in 3-OH-AHL synthesis probably use D-3-hydroxy-ketoacyl-ACP substrates from the Fab cycle. Other biosynthetic pathways, including the phospholipid, lipopolysaccharide, haemolysin and other pathways, also use acyl-ACP intermediates. Other abbreviations : ACC, acetyl-CoA carboxylase ; ACP, acyl carrier protein ; FabH, β-ketoacyl ACP synthase III.
chains from the cellular acyl-ACP (acyl carrier protein) pool More! et al., 1996 ; Parsek et al., 1999 ; Val & Cronan, 1998) (Fig. 1) . Acyl chain specificity resides in critical amino acid residues within the AHL synthase sequences (Watson et al., 2002) . The AHL synthases (LasI for 3-oxo-C "# -HSL and RhlI for C % -HSL) are sufficient for catalysis of the acyl transfer and lactonization reactions (More! et al., 1996 ; Parsek et al., 1999 ; Hoang et al., 1999) . P. aeruginosa culture supernatants contain 3-oxo-AHLs with various acyl chain lengths but their metabolic origins have not been elucidated. In this study, we attempted to elucidate the molecular basis for the synthesis of these 3-oxo-AHLs. Since LasI competes with NADPH-dependent β-ketoacyl-ACP reductase, FabG, for the 3-oxo-acyl-ACP precursors for synthesis of these 3-oxo-AHLs (Fig. 1) , we reasoned that FabG activity may be a modulating factor determining acyl chain lengths in 3-oxo-AHLs. Because most Fab (fatty acid biosynthesis) enzymes, including FabG, are essential, conventional mutant analysis cannot be used to address their roles in cellular metabolism. To circumvent these problems, a complete in vitro Fab system using purified Escherichia coli Fab proteins and ACP was previously described and was shown to produce the types and distribution of acyl-ACP species found in vivo (Heath & Rock, 1996a, b) . Since the E. coli and P. aeruginosa Fab systems are quite similar, we reasoned P. aeruginosa homoserine lactone synthesis that an in vitro Fab-3-oxo-AHL synthesis system could be used to explore FabG activity as a factor determining acyl chain lengths of 3-oxo-AHLs. To this end, we purified the P. aeruginosa Fab proteins as hexahistidine (H ' ) fusion proteins and developed an in vitro Fab-AHL synthesis system by coupling them to purified LasI. Some of the observations made with the in vitro system were supported by preliminary in vivo data obtained with a conditional, temperature-sensitive fabG(Ts) mutant.
METHODS
Strains and growth media. Escherichia coli strains used in this study were DH5α (Liss, 1987) , BL21(DE3) (Novagen), SA1503(DE3) and the 3-oxo-C "# -HSL reporter strain MG4\pKDT17 (lasR + lasB-lacZ) (Schaefer et al., 2000) . The wild-type P. aeruginosa strain PAO1 was previously described (Watson & Holloway, 1978) . P. aeruginosa strain 4 is a clinical wound isolate from the Glaxo SmithKline collection and is similar to PAO1 in terms of extracellular protein profiles, exoenzyme S production and nucleotide sequences. The fabG(Ts) mutant ts-67 was derived from strain 4 by Dr J. Huang (Collegeville, PA, USA) at Glaxo SmithKline and strain ts-67R1 is a revertant of strain ts-67. The Agrobacterium tumefaciens strains NTL4\pZLR4 (containing traR and traG ::lacZ) and NT1\pTiC58∆accR were from S. Farrand (University of Illinois, Urbana, USA). The Erwinia carotovora strain EC14 was previously described (Schweizer, 1994) . Unless otherwise indicated, bacterial strains were grown in LB medium (Difco), which for plasmid maintenance in E. coli was supplemented with 100 µg ampicillin ml − " and\or 25 µg chloramphenicol ml − ".
Construction of expression vectors and affinity purification of proteins. The coding sequences for the individual enzymes were PCR amplified from PAO1 genomic DNA utilizing Taq polymerase and previously described conditions Hoang et al., 1998) . The general strategy involved the use of a forward primer that incorporated an NdeI restriction site at the start codon of the respective gene and a reverse primer that incorporated a BamHI restriction site after the stop codon of the same gene (Table 1 ). The gel- The forward primers incorporated an NdeI restriction site (underlined) at the start codon of the respective genes. In most cases, the reverse primers incorporated a BamHI restriction site (underlined) after the stop codon with the exception of FabG (reverse), which incorporated a BglII site after the fabG stop codon.
Name
Sequence (5h-3h)
GAGGATCCATCAAACTCATAGTTTGCGT purified (QIAquick gel extraction kit ; Qiagen) PCR fragments were digested with NdeI\BamHI and then ligated between the same sites of pET-15b (Novagen). Since fabG contained a BamHI site, the reverse primer incorporated a BglII site, which allowed subcloning into the BamHI site of pET-15b. Standard molecular biological techniques were used (Sambrook & Russell, 2001 ). Subcloning into pET-15b yielded the expression vectors pPS837 (FabB), pPS980 (FabG), pPS998 (FabH) and pPS937 (FabZ). For FabA, the PCR fragment was first cloned into the TA cloning vector pGEM-T (Promega) to yield pPS847. An NdeI-BamHI fragment derived from this plasmid was then subcloned between the same sites of pET-15b (Novagen) to yield the FabA expression vector pPS848. For expression of the resulting proteins with NH # -terminal hexahistidine (H ' ) tags, the plasmids were transformed into BL21(DE3) (Novagen). Screening of H ' -Fab protein-expressing transformants, cell lysis and purification of the soluble fusion proteins on Ni# + agarose affinity columns (Qiagen) was performed as previously described , except for FabD. Since FabD eluted from the columns with 40 mM imidazole, washing of the column was done with 30 bed vols buffer with 20 mM imidazole.
ACP was purified via an intein chitin-binding domain fusion protein as previously described (Kutchma et al., 1999) , except that it was coexpressed with acyl-ACP synthase (AcpS) to maximize holo-ACP formation. To this end, the AcpS expressing pPS1118 was constructed by subcloning the acpS gene from E. coli on a 470 bp AseI-HindIII fragment from pDPJ (Lambalot & Walsh, 1995) between the same sites of pACYC184 (Chang & Cohen, 1978) . For coexpression of ACP and AcpS, the expression strain was grown in LB j ampicillin j chloramphenicol medium to maintain the acpP-and acpScontaining plasmids. H ' -LasI was purified using a published procedure .
Protein concentrations were determined using the Bradford dye-binding assay (Bio-Rad) and BSA as the standard. Proteins were analysed by electrophoresis on 0n1 % SDS-10 % polyacrylamide gels (SDS-PAGE) (Makowski & Ramsby, 1993) and visualized by staining with Coomassie Brilliant Blue R-250 (Chen et al., 1993) .
Complementation assays. The coding sequences for the H ' -tagged FabA, FabB and FabD proteins were subcloned into the broad-host-range vector pUCP21T (Schweizer et al., 1996) (Hoang et al., 1998) into strain PAO191 (fabA) and PAO192 (fabB) (Hoang & Schweizer, 1997) , respectively. Since FabA and FabB are required for unsaturated fatty acid synthesis, PAO191 and PAO192 will not grow at 42 mC unless supplemented with oleic acid or complemented with either a FabA-or FabB-expressing plasmid. Complementation was therefore scored as the ability to grow at 42 mC on RB medium without oleate supplementation (Hoang & Schweizer, 1997) . To test for expression of a functional H ' -FabD protein, pPS1019 was transformed into the fabD(Ts) mutant PAO204 (Kutchma et al., 1999) . Successful complementation was scored as the ability of the transformants to grow on LB plates at 42 mC. In all instances, strains were transformed with pUCP21T as a negative control.
Reconstitution of the Fab-AHL pathway and extraction of 3-oxo-acyl-HSLs. Complete reactions (total volume 500 µl) contained buffer [10 mM Tris\HCl (pH 7n4), 330 mM NaCl, 15 %, w\v, glycerol, 0n7 mM DTT, 2 mM EDTA, 25 mM MgSO % , 0n1 mM FeSO % ] (More! et al., 1996) , 2 µg ACP, 1 µg each FabA, FabB, FabD, FabH, FabI and FabZ, 0n5 µg FabG, 5 µg LasI, 0n25 mM SAM, 0n08 mM acetylCoA, 0n8 mM malonyl-CoA and 0n6 mM each NADH and NADPH (substrates and cofactors were obtained from Sigma). Reactions were incubated at 37 mC for 1 h and extracted three times with 250 µl ethyl acetate. Extracted AHLs were dried by rotary vacuum evaporation and resuspended in 20 µl acetonitrile. For detection of fractions containing AHLs, 5-10 µl each fraction was spotted on a C ") reverse-phase TLC plate (Whatman) and the plates were dried at 37 mC for 15 min before being overlaid with the detection strain. For TLC analysis of AHL fractions, the plates were developed in 60 % methanol in water (v\v) and then dried for 20 min at 37 mC prior to being overlaid with the detection strain.
Detection, identification and quantification of AHLs. A. tumefaciens reporter strain NTL4\pZLR4 was grown at 30 mC for 48 h in M9 medium (Miller, 1992) with 1 mM MgSO % , 0n1 mM CaCl # , 0n6 % glucose and 30 µg gentamicin ml − " (Shaw et al., 1997) . Cells were harvested and resuspended in warm ("45 mC) fresh M9 medium with 0n4 % agar, 1 mM MgSO % , 0n1 mM CaCl # , 0n6 % glucose and 40 µg X-Gal ml − ". This suspension was used immediately to overlay the TLC plates. The presence of AHLs was usually evident by the appearance of blue spots after incubation at room temperature for 36-48 h. Synthetic 3-oxo-C "# -HSL, and bacterial-derived 3-oxo-C ) -HSL and 3-oxo-C ' -HSL were included as standards. The latter two were extracted from 10 ml stationary-phase clarified culture supernatants of A. tumefaciens strain NT1\ pTiC58∆accR or Erw. carotovora strain EC14, respectively, using a previously described method (Shaw et al., 1997) . The concentrations of 3-oxo-C "# -HSL were estimated utilizing the Esc. coli reporter strain MG4\pKDT17 (lasR + lasB-lacZ) as previously described (Schaefer et al., 2000) and by using a dilution series of synthetic 3-oxo-C "# -HSL to establish a standard curve. For determination of HSL levels in the supernatants of the fabG(Ts) mutant ts-67, its parental strain 4 and the ts-67R1 revertant of strain ts-67, the strains were grown in LB medium until the cultures reached an optical density of "1n6 (600 nm). The pH in the cultures was monitored to avoid excess alkalinization of the medium since AHLs are very unstable at alkaline pH values (Schaefer et al., 2000) . Aliquots (1 ml) were harvested by centrifugation. The supernatants were extracted three times with 1 ml acidified ethyl acetate (ethyl acetate containing 0n1 ml glacial acetic acid per litre), dried and suspended in 200 µl acidified ethyl acetate. For detection of fractions containing 3-oxo-HSLs, 10 µl each fraction was spotted on a C ") reverse-phase TLC plate. The plates were processed as described above and then overlaid with the A. tumefaciens detection strain.
RESULTS AND DISCUSSION

Purification and in vivo activity of Fab proteins
Our initial goal was to set up a complete in vitro Fab-AHL synthesis system using only P. aeruginosa proteins by coupling purified Fab enzymes to LasI 3-oxo-AHL synthase. Since we previously described the purification and activity of ACP (Kutchma et al., 1999) , FabD (Kutchma et al., 1999) , FabI and LasI , we still needed to purify FabA, FabB, FabG, FabH and FabZ, assuming that all of these proteins are needed to synthesize acyl-ACPs from acetyl-CoA and malonyl-CoA (Fig. 1) . Using nondenaturing conditions and metal chelation affinity chromatography, all Fab proteins were purified to near homogeneity after overexpression in E. coli (Fig. 2) expressed H ' -FabI complemented an E. coli fabI(Ts) mutant and was enzymically active . Complementation experiments were not possible for FabH and FabZ since no mutants were available.
Establishment of an in vitro Fab-3-oxo-AHL synthesis system
The Fab-3-oxo-AHL pathway was reconstituted in vitro and biologically active 3-oxo-AHLs were detected using an A. tumefaciens indicator strain (Fig. 3) . The results showed that the minimal Fab-3-oxo-AHL biosynthetic pathway consists of ACP, FabB, FabD, FabG, FabI, FabZ and LasI. Essential metabolites included malonylCoA and SAM. Lesser amounts of 3-oxo-AHLs were produced when acetyl-CoA and NADH were omitted. While our experiments confirmed the previously established importance of some components of the Fab system in AHL synthesis, i.e. the dependency on ACP, metabolites and cofactors (More! et al., 1996 ; Parsek et al., 1999 ; Val & Cronan, 1998) , the minimal pathway was to date unknown and could not have been determined without establishing the experimental system described in this study. The in vitro system also allowed an assessment of the relative contribution of the seemingly redundant components of the Fab system. Synthases. Since FabB is the major condensing enzyme, it was essential for AHL formation from malonyl-CoA. In contrast, FabH was not required presumably since FabB can decarboxylate malonyl-ACP to acetyl-ACP and then condenses these two molecules to initiate the cycle without FabH (Fig. 1) , as has been suggested for E. coli FabB (Cronan & Rock, 1996) . This would also explain the formation of 3-oxo-AHLs in the reactions containing no acetyl-CoA.
Dehydratases. Of the two dehydratases, only FabZ was essential for AHL formation but not FabA. This is probably due to the fact that FabZ is mostly required in the initial cycles since its E. coli counterpart has greatest affinity for C % -C ) β-hydroxyacyl-ACP intermediates, but can use substrates with longer acyl chains (Heath & Rock, 1996a) . In contrast, E. coli FabA acts preferably on C "! -C "% β-hydroxyacyl-ACP intermediates.
Reductants. Exclusion of NADH led to detectable AHL production but at much reduced levels. Since NADH is the reductant preferred by FabI , this result indicates that FabI can utilize NADPH but that this step becomes rate-limiting in the absence of NADH.
When the known Fab inhibitors cerulenin, triclosan, diazoborine and thiolactomycin were added to the reaction mixture, only cerulenin and triclosan efficiently inhibited 3-oxo-AHL formation at the concentration tested (50 µM). For unknown reasons, at the same concentrations, thiolactomycin and diazoborine had little effect but from other experiments we suspected that these two antimicrobials, which are not available commercially, had lost much of their activities during storage (data not shown).
Nature of AHL molecules synthesized in vitro
TLC analysis (Fig. 4) was used to identify AHL species contained in representative positive reactions shown in Fig. 3 . The analysis showed that reactions containing all essential components of the Fab-3-oxo-AHL synthesis system almost exclusively yielded 3-oxo-C "# -HSL, and only minute amounts of shorter chain 3-oxo-AHLs were discernible. Conversely, in the absence of NADPH but presence of NADH, LasI synthesized hardly any 3-oxo-C "# -HSL but larger amounts of 3-oxo-C "! -HSL and 3-oxo-C ) -HSL, and lesser amounts of 3-oxo-C ' -HSL (lane labelled -NADPH). Since 3-oxo-C ) -HSL is the cognate A. tumefaciens AHL, its spot size is not indicative of a higher quantity of 3-oxo-C ) -HSL relative to the other 3-oxo-AHLs, but rather indicates a better response to its native AHL. According to the pathway model (Fig. 1) , LasI and FabG compete for 3-oxo-acyl-ACP substrates from the Fab system. Although FabG can utilize NADH, NADPH is its preferred cofactor and in its absence the FabG-catalysed reduction step becomes rate limiting, leading to accumulation of shorter chain 3-oxo-acyl- (pZLR4) detection strain in the presence of X-Gal. All, complete reaction mixtures contained ACP, FabA, FabB, FabD, FabG, FabH, FabI, FabZ, LasI, SAM, acetyl-CoA, malonyl-CoA, and NADH and NADPH ; other reactions lacked the indicated enzymes, substrates or co-factors. The relative mobility of known 3-oxoacyl-HSLs, analysed on the same TLC plate but in a portion that is not shown, and the sample origin are marked on the right.
ACPs. This now enables LasI to compete for the shorterchain 3-oxo-acyl-ACP substrates and use them for synthesis of the corresponding shorter chain 3-oxoAHLs. These results also proved that LasI alone is sufficient for synthesis of the shorter chain 3-oxo-AHLs found in P. aeruginosa culture supernatants.
A fabG(Ts) mutant is altered in 3-oxo-AHL production A fabG(Ts) mutant was used to obtain preliminary in vivo experimental evidence for some of the in vitro observations. To examine whether altered FabG activity influenced 3-oxo-AHL production in vivo, AHL formation was analysed in a fabG(Ts) mutant grown in LB medium at permissive temperature (30 mC) and 37 mC, a temperature that is close to non-permissive (38 mC or higher). The fabG(Ts) mutant produced elevated levels of all 3-oxo-AHLs at both temperatures, most notably 3-oxo-C ' -HSL which under these experimental conditions was undetectable in supernatants obtained from wildtype and revertant strains, respectively (Fig. 5) . Whereas the parental wild-type and the revertant strain produced levels of 3-oxo-C "# -HSL that remained nearly constant over the temperature range examined, the fabG(Ts) strain produced elevated levels of this 3-oxo-AHL, which increased with increasing temperatures (Table 2) . These increasing 3-oxo-C "# -HSL levels were paralleled with a slight decrease in growth rates of the fabG(Ts) mutant as the temperature increased. The doubling strain, its parent and a revertant. AHLs were extracted from cells grown at the indicated temperatures and samples of the concentrated reaction products were spotted onto a C 18 -reverse phase TLC plate. The plate was developed with 60 % (v/v) methanol in water and overlaid with the A. tumefaciens NTL4(pZLR4) detection strain in the presence of X-Gal. Samples analysed were from wild-type strain 4 (WT), its fabG(Ts) derivative (TS) and a revertant that contained a restored wildtype fabG sequence (RE). Standards included 3-oxo-C 6 -HSL (C 6 ), 3-oxo-C 8 -HSL (C 8 ) and 3-oxo-C 12 -HSL (C 12 ). The relative mobility of 3-oxo-C 10 -HSL (C 10 ), for which no standard was available, and the origin (O) are marked on the right. times at 37 mC were 24 min for wild-type and revertant, and 36 min for the fabG(Ts) mutant. Similar observations to those presented in Fig. 5 and Table 2 were made when AHLs were extracted from cultures grown to lesser cell densities (data not shown). The most plausible explanation for these observations is that even at permissive temperatures the fabG(Ts) strain produces a FabG protein whose reductase activity is decreased when compared to wild-type or revertant FabG. Decreased FabG activity would lead to an increase in the intracellular 3-oxo-acyl-ACP pools, enabling LasI to compete for these substrates, ultimately resulting in increased 3-oxo-acyl-HSL levels.
Conclusions
The 3-oxo-AHLs normally found in P. aeruginosa culture supernatants contain acyl chains of 6-12 carbons (Shaw et al., 1997 ) and the relative abundances of different 3-oxo-AHLs change during growth. The results obtained with our in vitro system gave the first clues that modulation of FabG activity by substrate and\or cofactor availability may at least partially explain these observations. In the presence of LasI, this AHL synthase The strains were grown in LB medium to OD '!! "1n6 at the indicated temperatures. One millilitre aliquots were harvested by centrifugation. The supernatants were extracted three times with 1 ml acidified ethyl acetate, dried and suspended in 200 µl acidified ethyl acetate. The concentrations of 3-oxo-C "# -HSL were estimated using the E. coli reporter strain MG4\pKDT17 (lasR + lasB-lacZ) and a dilution series of synthetic 3-oxo-C "# -HSL to establish a standard curve. The values shown are the meanspstandard deviations of triplicate measurements.
Strain
Extracellular 3-oxo-C 12 -HSL (nM) and FabG compete for 3-oxo-acyl-ACP substrates from the fatty acid biosynthetic pathway. When FabG activity is high, turnover of the short chain 3-oxo-acyl-ACP substrates is rapid and LasI cannot compete for them, presumably because its affinity for them is lower than that of FabG. Once the acyl chain length reaches 12 carbons, LasI efficiently competes for the 3-oxo-C "# -ACP, resulting in synthesis of 3-oxo-C "# -HSL. When the FabG catalysed step becomes rate limiting, as mimicked in our experimental system by switching cofactors from the preferred NADPH to NADH, accumulation of shorter chain 3-oxo-acyl-ACPs results. This enables LasI to compete for these shorter-chain 3-oxo-acyl-ACP substrates and use them for synthesis of the corresponding shorter chain 3-oxo-AHLs. This explains why in the absence of NADPH only minute amounts of 3-oxo-C "# -HSL were synthesized in the in vitro reactions, while the levels of 3-oxo-C ) -HSL and 3-oxo-C "! -HSL were greatly elevated (Fig. 4) . Consistent with these observations and conclusions, a fabG(Ts) mutant produced overall elevated levels of 3-oxo-AHLs, especially when it was grown at increasing temperatures ( Fig. 5 ; Table 2 ), presumably since the respective 3-oxo-acylACPs become available for LasI as the growth rate and therefore the demand for fatty acids for other biosynthetic processes decreases. The potential physiological relevance of 3-oxo-AHLs in P. aeruginosa other than 3-oxo-C "# -HSL, and the regulation of their relative abundances during cellular growth by modulation of FabG activity is currently unclear and awaits further investigation. FabG activity may be controlled at the genetic level (e.g. via transcriptional regulation of fabG) or at the protein level (via substrate allosteric effects).
